79 related articles for article (PubMed ID: 12578714)
1. [Promotion of Thrombopoiesis by rhIL-11 in Normal and Myelosuppressed Mice].
Zuo C; Xu M; Wang Y; Yi H; Feng Y; Li T; Liu X; Huang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Mar; 8(1):24-30. PubMed ID: 12578714
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic Effects of rhIL-11 on Carboplatin-Induced Thrombocytopenia in Monkeys].
Zuo C; Xu M; Wang Y; Yi H; Feng Y; Li T; Liu X; Huang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Mar; 8(1):31-36. PubMed ID: 12578715
[TBL] [Abstract][Full Text] [Related]
3. [Thrombocytopoietic Efficacy of Pegylated Recombinant Human Interleukin-11 Mutein in Myelosuppressed Mice].
Ma SS; Ho SH; Wang HL; Nie LY; Xu SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1511-1517. PubMed ID: 27784384
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice.
Saitoh M; Taguchi K; Momose K; Suga K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Mar; 13(5):287-94. PubMed ID: 11243707
[TBL] [Abstract][Full Text] [Related]
6. Effects of rhIL-11 on normal dogs and after sublethal radiation.
Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
[TBL] [Abstract][Full Text] [Related]
7. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic Effect of rhIL-11 on Thrombocytopenia Induced by Carboplatin in Rhesus Monkeys].
Lu Q; Wen L; Guo S; Sun Z; Chen Y; Li Y; Gao Y; Dong B; Liu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Jun; 8(2):129-132. PubMed ID: 12578703
[TBL] [Abstract][Full Text] [Related]
9. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P
Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells.
Saitoh M; Taguchi K; Momose K; Suga K; Yamazaki N; Ono C; Suzuki T; Takeuchi O; Yasuda S; Miyata K
Cancer Chemother Pharmacol; 2002 Feb; 49(2):161-6. PubMed ID: 11862431
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effects of rhIL-11 on Irradiation-Induced Myelosuppression in Rhesus Monkeys.
Hao J; Luo QL; Xiong GL; Liu XL; Qiu LL; Chen GZ; Huang Y; Ge P; Geng Y; Sun LS; Dong B; Li YM; Chen WQ; Shen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar; 9(1):56-61. PubMed ID: 12578647
[TBL] [Abstract][Full Text] [Related]
13. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of rhIL-11.
Reynolds CH
Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):32-40. PubMed ID: 11033836
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
Li L; Xu CG; Wang XW; Guo QS; Sun YH; Sun LM
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
Schlerman FJ; Bree AG; Kaviani MD; Nagle SL; Donnelly LH; Mason LE; Schaub RG; Grupp SA; Goldman SJ
Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
[TBL] [Abstract][Full Text] [Related]
17. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
[TBL] [Abstract][Full Text] [Related]
18. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
[TBL] [Abstract][Full Text] [Related]
19. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
Kaye JA
Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant Human Interleukin 11 (Mega) Promotes Thrombopoiesis in Cancer Patients with Chemotherapy-Induced Myelosuppression].
Chu DT; Xu BH; Song ST; Mao XH; Jiao SC; Zhang AL; Cong J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Dec; 9(4):314-317. PubMed ID: 12578570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
